Double-Targeting using a Trkc ligand conjugated to dipyrrometheneboron difluoride (BODIPY) based photodynamic therapy (PDT) agent

Journal of Medicinal Chemistry

Volumn 56, Issue 19, 2013, Pages 7608-7614

  Kamkaew, Anyanee ^a   Burgess, Kevin ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DIPYRROMETHENEBORON DIFLUORIDE; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ARTICLE; CELL ENGINEERING; CELL LINE; CELL TYPE; CYTOTOXICITY; DRUG STRUCTURE; LYSOSOME; NEUROBLASTOMA CELL; PHOTODYNAMIC THERAPY; TRKC CELL;

ANIMALS; BORON COMPOUNDS; CELL LINE, TUMOR; HUMANS; LIGANDS; LYSOSOMES; MICE; NIH 3T3 CELLS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RECEPTOR, TRKC;

EID: 84885617174     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm4012142     Document Type: Article

References (48)

1. Chabner, B. A.; Roberts, T. G. Chemotherapy and the war on cancer Nat. Rev. Cancer 2005, 5, 65-72
2. Zhang, J.; Yang, P. L.; Gray, N. S. Targeting cancer with small molecule kinase inhibitors Nat. Rev. Cancer 2009, 9, 28-39
3. Prien, O. Target-family-oriented focused libraries for kinases-conceptual design aspects and commercial availability ChemBioChem 2005, 6, 500-505
4. Barnett, S. F.; Bilodeau, M. T.; Lindsley, C. W. The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation Curr. Top. Med. Chem. 2005, 5, 109-125
5. Schrama, D.; Reisfeld, R. A.; Becker, J. C. Antibody targeted drugs as cancer therapeutics Nat. Rev. Drug Discovery 2006, 5, 147-159
6. Sievers, E. L.; Senter, P. D. Antibody-drug conjugates in cancer therapy Annu. Rev. Med. 2013, 64, 15-29
7. Xia, W.; Low, P. S. Folate-targeted therapies for cancer J. Med. Chem. 2010, 53, 6811-6824
8. Low, P. S.; Kularatne, S. A. Folate-targeted therapeutic and imaging agents for cancer Curr. Opin. Chem. Biol. 2009, 13, 256-262
9. Lu, Y.; Low Philip, S. Folate-mediated delivery of macromolecular anticancer therapeutic agents Adv. Drug Delivery Rev. 2012, 64, 342-352
10. Hilgenbrink, A. R.; Low, P. S. Folate receptor-mediated drug targeting: from therapeutics to diagnostics J. Pharm. Sci. 2005, 94, 2135-2146
11. Desgrosellier, J. S.; Cheresh, D. A. Integrins in cancer: biological implications and therapeutic opportunities Nat. Rev. Cancer 2010, 10, 9-22
12. Schmitt, F.; Juillerat-Jeanneret, L. Drug targeting strategies for photodynamic therapy Anti-Cancer Agents Med. Chem. 2012, 12, 500-525
13. Verma, S.; Watt, G. M.; Mai, Z.; Hasan, T. Strategies for enhanced photodynamic therapy effects Photochem. Photobiol. 2007, 83, 996-1005
14. Sharman, W. M.; van Lier, J. E.; Allen, C. M. Targeted photodynamic therapy via receptor mediated delivery systems Adv. Drug Delivery Rev. 2004, 56, 53-76
15. Kamkaew, A.; Lim, S. H.; Lee, H. B.; Kiew, L. V.; Chung, L. Y.; Burgess, K. BODIPY dyes in photodynamic therapy Chem. Soc. Rev. 2012, 42, 77-88
16. Awuah, S. G.; You, Y. Boron dipyrromethene (BODIPY)-based photosensitizers for photodynamic therapy RSC Adv. 2012, 2, 11169-11183
17. Ko, E.; Kamkaew, A.; Burgess, K. Small molecules ligands for active targeting of TrkC-expressing tumor cells ACS Med. Chem. Lett. 2012, 3, 1008-1012
18. Yogo, T.; Urano, Y.; Ishitsuka, Y.; Maniwa, F.; Nagano, T. Highly efficient and photostable photosensitizer based on BODIPY chromophore J. Am. Chem. Soc. 2005, 127, 12162-12163
19. Lim, S. H.; Thivierge, C.; Nowak-Sliwinska, P.; Han, J.; Van den Bergh, H.; Wagnieres, G.; Burgess, K.; Lee, H. B. In vitro and in vivo photo-cytotoxicity of boron dipyrromethene derivatives for photodynamic therapy J. Med. Chem. 2010, 53, 2865-2874
20. Chen, D.; Brahimi, F.; Angell, Y.; Li, Y.-C.; Moscowicz, J.; Saragovi, H. U.; Burgess, K. Bivalent peptidomimetic ligands of TrkC are biased agonists, selectively induce neuritogenesis, or potentiate neurotrophin-3 trophic signals ACS Chem. Biol. 2009, 4, 769-781
21. Yamashiro, D. J.; Nakagawara, A.; Ikegaki, N.; Liu, X. G.; Brodeur, G. M. Expression of TrkC in favorable human neuroblastomas Oncogene 1996, 12, 37-41
22. Segal, R. A.; Goumnerova, L. C.; Kwon, Y. K.; Stiles, C. D.; Pomeroy, S. L. Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 12867-12871
23. Jin, W.; Kim, G.-M.; Kim, M.-S.; Lim, M.-H.; Yun, C.-H.; Jeong, J.; Nam, J.-S.; Kim, S.-J. TrkC plays an essential role in breast tumor growth and metastasis Carcinogenesis 2010, 31, 1939-1947
24. Truzzi, F.; Marconi, A.; Pincelli, C. Neurotrophins in healthy and diseased skin Derm.-Endocrinol. 2011, 3, 32-36
25. Pincelli, C.; Dallaglio, K.; Truzzi, F. Melanoma and the Nervous System-Novel Pathways Mediated by Neurotrophins and Their Receptors. Breakthroughs in Melanoma Research; Tanaka, Y., Ed.; InTech: New York, 2011; DOI 10.5772/22053; available from http://www.intechopen.com/books/breakthroughs-in- melanoma-research/melanoma-and-the-nervous-system-novel-pathways-mediated-by- neurotrophins-and-their-receptors.
26. Truzzi, F.; Marconi, A.; Lotti, R.; Dallaglio, K.; French, L. E.; Hempstead, B. L.; Pincelli, C. Neurotrophins and their receptors stimulate melanoma cell proliferation and migration J. Invest. Dermatol. 2008, 128, 2031-2040
27. Xu, X.; Tahan, S. R.; Pasha, T. L.; Zhang, P. J. Expression of neurotrophin receptor Trk-C in nevi and melanomas J. Cutaneous Pathol. 2003, 30, 318-322
28. Innominato, P. F.; Libbrecht, L.; van den Oord, J. J. Expression of neurotrophins and their receptors in pigment cell lesions of the skin J. Pathol. 2001, 194, 95-100
29. Meldal, M.; Tornoe, C. W. Cu-catalyzed azide-alkyne cycloaddition Chem. Rev. 2008, 108, 2952-3015
30. Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Click chemistry: diverse chemical function from a few good reactions Angew. Chem., Int. Ed. 2001, 40, 2004-2021
31. Ballou, B.; Ernst, L. A.; Waggoner, A. S. Fluorescence imaging of tumors in vivo Curr. Med. Chem. 2005, 12, 795-805
32. Guillemard, V.; Ivanisevic, L.; Garcia, A. G.; Scholten, V.; Lazo, O. M.; Bronfman, F. C.; Saragovi, H. U. An agonistic mAb directed to the TrkC receptor juxtamembrane region defines a trophic hot spot and interactions with p75 coreceptors Dev. Neurobiol. 2010, 70, 150-164
33. Encinas, M.; Iglesias, M.; Llecha, N.; Comella, J. X. Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y J. Neurochem. 1999, 73, 1409-1421
34. Butowt, R.; von Bartheld, C. S. Sorting of internalized neurotrophins into an endocytic transcytosis pathway via the Golgi system: ultrastructural analysis in retinal ganglion cells J. Neurosci. 2001, 21, 8915-8930
35. Bosanquet, A. G.; Bell, P. B. Ex vivo therapeutic index by drug sensitivity assay using fresh human normal and tumor cells J. Exp. Ther. Oncol. 2004, 4, 145-154
36. Uhlen, M.; Oksvold, P.; Fagerberg, L.; Lundberg, E.; Jonasson, K.; Forsberg, M.; Zwahlen, M.; Kampf, C.; Wester, K.; Hober, S.; Wernerus, H.; Bjoerling, L.; Ponten, F. Towards a knowledge-based Human Protein Atlas Nat. Biotechnol. 2010, 28, 1248-1250
37. Rao, J.; Dragulescu-Andrasi, A.; Yao, H. Fluorescence imaging in vivo: recent advances Curr. Opin. Biotechnol. 2007, 18, 17-25
38. Frangioni, J. V. In vivo near-infrared fluorescence imaging Curr. Opin. Chem. Biol. 2003, 7, 626-34
39. Sevick-Muraca, E. M.; Houston, J. P.; Gurfinkel, M. Fluorescence- enhanced, near infrared diagnostic imaging with contrast agents Curr. Opin. Chem. Biol. 2002, 6, 642-50
40. Gallagher, W. M.; Allen, L. T.; O'Shea, C.; Kenna, T.; Hall, M.; Gorman, A.; Killoran, J.; O'Shea, D. F. A potent nonporphyrin class of photodynamic therapeutic agent: cellular localization, cytotoxic potential and influence of hypoxia Br. J. Cancer 2005, 92, 1702-1710
41. McDonnell, S. O.; Hall, M. J.; Allen, L. T.; Byrne, A.; Gallagher, W. M.; O'Shea, D. F. Supramolecular photonic therapeutic agents J. Am. Chem. Soc. 2005, 127, 16360-16361
42. Quartarolo, A. D.; Russo, N.; Sicilia, E. Structures and electronic absorption spectra of a recently synthesised class of photodynamic therapy agents Chem.-Eur. J. 2006, 12, 6797-6803
43. Byrne, A. T.; O'Connor, A. E.; Hall, M.; Murtagh, J.; O'Neill, K.; Curran, K. M.; Mongrain, K.; Rousseau, J. A.; Lecomte, R.; McGee, S.; Callanan, J. J.; O'Shea, D. F.; Gallagher, W. M. Vascular-targeted photodynamic therapy with BF2-chelated tetraaryl-azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment Br. J. Cancer 2009, 101, 1565-1573
44. Batat, P.; Cantuel, M.; Jonusauskas, G.; Scarpantonio, L.; Palma, A.; O'Shea, D. F.; McClenaghan, N. D. BF2-azadipyrromethenes: probing the excited-state dynamics of a NIR fluorophore and photodynamic therapy agent J. Phys. Chem. A 2011, 115, 14034-14039
45. Erbas, S.; Gorgulu, A.; Kocakusakogullari, M.; Akkaya, E. U. Non-covalent functionalized SWNTs as delivery agents for novel BODIPY-based potential PDT sensitizers Chem. Commun. 2009, 4956-4958
46. Cakmak, Y.; Kolemen, S.; Duman, S.; Dede, Y.; Dolen, Y.; Kilic, B.; Kostereli, Z.; Yildirim, L. T.; Dogan, A. L.; Guc, D.; Akkaya, E. U. Designing excited states: theory-guided access to efficient photosensitizers for photodynamic action Angew. Chem., Int. Ed. 2011, 50, 11937-11941
47. He, H.; Lo, P.-C.; Yeung, S.-L.; Fong, W.-P.; Ng, D. K. P. Preparation of unsymmetrical distyryl BODIPY derivatives and effects of the styryl substituents on their in vitro photodynamic properties Chem. Commun. 2011, 47, 4748-4750
48. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 1983, 65, 55-63